Azetukalner Psychiatry Enrollment Pause

Company Xenon Pharmaceuticals Event Type Enrollment Pause (Psychiatry) / NDA Submission (Epilepsy) Modality Oral, Selective Kv7 Potassium-Channel Opener Asset Azetukalner Disease Area Focal Seizures; Major Depressive Disorder and Bipolar Depression Summary Xenon voluntarily paused enrollment of new participants in its Phase III major-depressive-disorder and bipolar-depression…